Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovate (VATE) EBT (2016 - 2025)

Innovate has reported EBT over the past 16 years, most recently at -$9.3 million for Q4 2025.

  • Quarterly results put EBT at -$9.3 million for Q4 2025, up 37.58% from a year ago — trailing twelve months through Dec 2025 was -$61.5 million (down 84.13% YoY), and the annual figure for FY2025 was -$61.5 million, down 84.13%.
  • EBT for Q4 2025 was -$9.3 million at Innovate, up from -$16.7 million in the prior quarter.
  • Over the last five years, EBT for VATE hit a ceiling of $11.4 million in Q2 2024 and a floor of -$41.8 million in Q1 2021.
  • Median EBT over the past 5 years was -$12.2 million (2022), compared with a mean of -$12.6 million.
  • Biggest five-year swings in EBT: soared 208.57% in 2024 and later tumbled 247.37% in 2025.
  • Innovate's EBT stood at -$3.7 million in 2021, then crashed by 116.22% to -$8.0 million in 2022, then dropped by 16.25% to -$9.3 million in 2023, then plummeted by 60.22% to -$14.9 million in 2024, then skyrocketed by 37.58% to -$9.3 million in 2025.
  • The last three reported values for EBT were -$9.3 million (Q4 2025), -$16.7 million (Q3 2025), and -$16.8 million (Q2 2025) per Business Quant data.